284 related articles for article (PubMed ID: 19691357)
21. Strain-dependent disposition of inorganic arsenic in the mouse.
Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Thomas DJ
Toxicology; 1999 Sep; 137(2):95-108. PubMed ID: 10521146
[TBL] [Abstract][Full Text] [Related]
22. Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10.
Gomez-Rubio P; Meza-Montenegro MM; Cantu-Soto E; Klimecki WT
J Appl Toxicol; 2010 Apr; 30(3):260-70. PubMed ID: 20014157
[TBL] [Abstract][Full Text] [Related]
23. Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
Canet MJ; Hardwick RN; Lake AD; Kopplin MJ; Scheffer GL; Klimecki WT; Gandolfi AJ; Cherrington NJ
Drug Metab Dispos; 2012 Sep; 40(9):1817-24. PubMed ID: 22699396
[TBL] [Abstract][Full Text] [Related]
24. Knockout of arsenic (+3 oxidation state) methyltransferase results in sex-dependent changes in phosphatidylcholine metabolism in mice.
Huang MC; Douillet CC; Stýblo M
Arch Toxicol; 2016 Dec; 90(12):3125-3128. PubMed ID: 27591999
[TBL] [Abstract][Full Text] [Related]
25. Arsenic Methyltransferase and Methylation of Inorganic Arsenic.
Roy NK; Murphy A; Costa M
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32971865
[TBL] [Abstract][Full Text] [Related]
26. Role of arsenic (+3 oxidation state) methyltransferase in arsenic metabolism and toxicity.
Sumi D; Himeno S
Biol Pharm Bull; 2012; 35(11):1870-5. PubMed ID: 23123458
[TBL] [Abstract][Full Text] [Related]
27. Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype.
Li J; Waters SB; Drobna Z; Devesa V; Styblo M; Thomas DJ
Toxicol Appl Pharmacol; 2005 Apr; 204(2):164-9. PubMed ID: 15808521
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing variants of human arsenic (+3 oxidation state) methyltransferase.
Sumi D; Fukushima K; Miyataka H; Himeno S
Biochem Biophys Res Commun; 2011 Nov; 415(1):48-53. PubMed ID: 22005461
[TBL] [Abstract][Full Text] [Related]
29. Diverse genetic backgrounds play a prominent role in the metabolic phenotype of CC021/Unc and CC027/GeniUNC mice exposed to inorganic arsenic.
Douillet C; Ji J; Meenakshi IL; Lu K; de Villena FP; Fry RC; Stýblo M
Toxicology; 2021 Mar; 452():152696. PubMed ID: 33524430
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy and the methyltransferase genotype independently influence the arsenic methylation phenotype.
Gardner RM; Engström K; Bottai M; Hoque WA; Raqib R; Broberg K; Vahter M
Pharmacogenet Genomics; 2012 Jul; 22(7):508-16. PubMed ID: 22547080
[TBL] [Abstract][Full Text] [Related]
31. Arsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals in the invertebrate chordate Ciona intestinalis.
Thomas DJ; Nava GM; Cai SY; Boyer JL; Hernández-Zavala A; Gaskins HR
Toxicol Sci; 2010 Jan; 113(1):70-6. PubMed ID: 19833739
[TBL] [Abstract][Full Text] [Related]
32. Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine.
Waters SB; Devesa V; Fricke MW; Creed JT; Stýblo M; Thomas DJ
Chem Res Toxicol; 2004 Dec; 17(12):1621-9. PubMed ID: 15606138
[TBL] [Abstract][Full Text] [Related]
33. Identification of an S-adenosylmethionine (SAM) dependent arsenic methyltransferase in Danio rerio.
Hamdi M; Yoshinaga M; Packianathan C; Qin J; Hallauer J; McDermott JR; Yang HC; Tsai KJ; Liu Z
Toxicol Appl Pharmacol; 2012 Jul; 262(2):185-93. PubMed ID: 22575231
[TBL] [Abstract][Full Text] [Related]
34. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms.
Agusa T; Fujihara J; Takeshita H; Iwata H
Int J Mol Sci; 2011; 12(4):2351-82. PubMed ID: 21731446
[TBL] [Abstract][Full Text] [Related]
35. Arsenite methyltransferase (AS3MT) polymorphisms and arsenic methylation in children in rural Bangladesh.
De Loma J; Skröder H; Raqib R; Vahter M; Broberg K
Toxicol Appl Pharmacol; 2018 Oct; 357():80-87. PubMed ID: 30153448
[TBL] [Abstract][Full Text] [Related]
36. Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.
Drobná Z; Walton FS; Harmon AW; Thomas DJ; Stýblo M
Toxicol Appl Pharmacol; 2010 May; 245(1):47-56. PubMed ID: 20138079
[TBL] [Abstract][Full Text] [Related]
37. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.
Thomas DJ; Li J; Waters SB; Xing W; Adair BM; Drobna Z; Devesa V; Styblo M
Exp Biol Med (Maywood); 2007 Jan; 232(1):3-13. PubMed ID: 17202581
[TBL] [Abstract][Full Text] [Related]
38. Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure.
Gribble MO; Tang WY; Shang Y; Pollak J; Umans JG; Francesconi KA; Goessler W; Silbergeld EK; Guallar E; Cole SA; Fallin MD; Navas-Acien A
Arch Toxicol; 2014 Feb; 88(2):275-82. PubMed ID: 24154821
[TBL] [Abstract][Full Text] [Related]
39. Association Between Variants in Arsenic (+3 Oxidation State) Methyltranserase (AS3MT) and Urinary Metabolites of Inorganic Arsenic: Role of Exposure Level.
Xu X; Drobná Z; Voruganti VS; Barron K; González-Horta C; Sánchez-Ramírez B; Ballinas-Casarrubias L; Cerón RH; Morales DV; Terrazas FA; Ishida MC; Gutiérrez-Torres DS; Saunders RJ; Crandell J; Fry RC; Loomis D; García-Vargas GG; Del Razo LM; Stýblo M; Mendez MA
Toxicol Sci; 2016 Sep; 153(1):112-23. PubMed ID: 27370415
[TBL] [Abstract][Full Text] [Related]
40. Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite.
Sánchez-Peña LC; Petrosyan P; Morales M; González NB; Gutiérrez-Ospina G; Del Razo LM; Gonsebatt ME
Environ Res; 2010 Jul; 110(5):428-34. PubMed ID: 20138265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
